Completion rate of tuberculosis preventive therapy and incidence of tuberculosis among people living with the Human Immunodeficiency Virus on antiretroviral therapy in Ekurhuleni East subdistrict, Gauteng province

• DOI: 10.11604/pamj.2024.48.86.43117
• Publication Date: 2024-07-04T08:48:43Z
• Authors: Refiloe Mashego M...; Lindiwe Cele; Mabina Mogale; Thembi Simbeni
• Keywords: Male; Adult; Adolescent; Anti-HIV Agents; Coinfection; Research; Incidence; Antitubercular Agents; HIV Infections; Middle Aged; Cohort Studies; South Africa; Young Adult; Cross-Sectional Studies; Humans; Tuberculosis; Female; Retrospective Studies

the World Health Organization (WHO) has recommended use of tuberculosis preventive therapy (TPT) as part a comprehensive care package for reduction (TB) incidence among people who are living with human immunodeficiency virus (PLWHA). When used optimally, TPT efficacy ranges between 60% and 90% adults children HIV. Despite wide adoption this intervention in South Africa, country remains heavily burdened high rates TB/HIV co-infections, reported to be 59% 2018. Reported challenges include low uptake completion rates. This study aimed determine rate investigate TB antiretroviral (ART) patients were initiated on TPT.